世界の体外診断（IVD）市場...市場調査レポートについてご紹介

Table Of Contents

1 Introduction (Page No. – 23)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
1.5.5 Assumptions

2 Executive Summary (Page No. – 30)

3 Market Overview (Page No. – 33)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers & Restraint
3.3.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Market
3.3.1.2 Rapidly Aging Population
3.3.1.3 Rise In Point-Of-Care (POC) Testing
3.3.1.4 Personalized Medicine To Propel Growth
3.3.1.5 Lack Of Budget To Restrict Growth
3.3.2 Opportunities
3.3.2.1 Extending Reach Of Molecular Diagnostics
3.3.2.2 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
3.3.3 Challenge
3.3.3.1 Stringent Regulatory Framework Acts As A Major Challenge
3.4 Winning Imperatives
3.4.1 Non-Proprietary System With Enhanced Functionalities
3.5 Burning Issues
3.5.1 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
3.6 Market Share Analysis
3.7 Supply Chain Analysis
3.8 Pestel Analysis
3.8.1 Political
3.8.2 Economic
3.8.3 Socio-Cultural
3.8.4 Technological
3.8.5 Environmental
3.8.6 Legal

4 By Technique (Page No. – 52)
4.1 Introduction
4.1.1 Clinical Chemistry
4.1.2 Immunochemistry/Immunoassay
4.1.3 Hematology
4.1.4 Coagulation
4.1.5 Microbiology
4.1.6 Molecular Diagnostics
4.1.7 Other Clinical Instruments

5 By Product Type (Page No. – 90)
5.1 Introduction
5.2 Instruments
5.3 Reagents
5.4 Data Management System Software/Hardware
5.5 Services

6 By Application (Page No. – 111)
6.1 Introduction
6.2 Diabetes
6.3 Infectious Diseases
6.4 Oncology/Cancer
6.5 Cardiology
6.6 Nephrology
6.7 Autoimmune Diseases
6.8 Drug Testing
6.9 HIV/Aids
6.10 Others

7 By End-User (Page No. – 158)
7.1 Introduction
7.2 Laboratory
7.3 Hospitals
7.4 Academics
7.5 Point-Of-Care Testing
7.6 Patient Self-Testing
7.7 Others

8 Geographic Analysis (Page No. – 164)
8.1 Introduction
8.2 Americas
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.2.4 Chile
8.2.5 Rest Of Americas (ROA)
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 Italy
8.3.4 Spain
8.3.5 U.K.
8.3.6 Rest Of Europe (ROE)
8.4 Japan
8.5 Bric
8.5.1 Brazil
8.5.2 Russia
8.5.3 India
8.5.4 China
8.6 Rest Of The World (ROW)

9 Competitive Landscape (Page No. – 243)
9.1 Introduction
9.2 New Product Launch
9.3 Agreements, Partnerships, Collaborations & Joint Ventures
9.4 Mergers And Acquisitions
9.5 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)* (Page No. – 282)
10.1 Abbott Laboratories, Inc.
10.2 Alere, Inc.
10.3 Arkray, Inc.
10.4 Bayer AG
10.5 Becton, Dickinson And Company
10.6 Biomerieux
10.7 Bio-Rad Laboratories, Inc.
10.8 Danaher Corporation
10.9 Diagnostica Stago Sas
10.10 Diasorin S.P.A.
10.11 Hologic, Inc.
10.12 Horiba, Ltd.
10.13 Johnson & Johnson
10.14 Novartis International Ag
10.15 Qiagen N.V.
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare
10.18 Sysmex Corporation
10.19 Thermo Fisher Scientific, Inc.
*Details On Financials, Products & Services, Developments & Strategy Might Not Be Captured In Case Of Unlisted Companies.